-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N1PUoq2WEML7wZ7LADEHmlGlSYVu6Sr7c6Rcev/1flgm56OQJ6EFjvP+xi01lKC+ A6fFRShhQbxpEKYJXDiaxw== 0000897069-09-000534.txt : 20090213 0000897069-09-000534.hdr.sgml : 20090213 20090213175156 ACCESSION NUMBER: 0000897069-09-000534 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090212 FILED AS OF DATE: 20090213 DATE AS OF CHANGE: 20090213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SABEL IVAN R CENTRAL INDEX KEY: 0001217563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 09605831 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 cmw4192_ex.xml X0303 4 2009-02-12 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217563 SABEL IVAN R TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 1 1 0 0 Chairman of the Board Common Stock 2009-02-12 4 M 0 7307 14.75 A 394757 D Common Stock 2009-02-12 4 S 0 7307 16.0296 D 387450 D Common Stock 1100 I Spouse's IRA Option to Buy 14.75 2009-02-12 4 M 0 7307 0 D 2000-04-29 2009-04-28 Common Stock 18000 10693 D Option to Buy 1.64 2002-05-31 2009-05-30 Common Stock 50000 50000 D Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 100000 100000 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 90000 90000 D These shares were sold at a range of sale prices from $16.00 to $16.13. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 31,350 shares of stock from an initial grant of 31,350 shares of restricted stock made on November 13, 2008; (ii) unvested restricted shares and fully vested shares which total 116,250 shares of stock from an initial grant of 155,000 shares of restricted stock and performance shares made on August 9, 2007; (iii) unvested restricted shares and fully vested shares which total 70,000 shares of stock from an initial grant of 140,000 shares of restricted stock made on June 12, 2006; and (iv) unvested restricted shares and fully vested shares which total 30,450 shares of stock from an initial grant of 75,000 shares of restricted stock made on March 4, 2005. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. This option was fully vested on June 23, 2005. /s/ Teri L. Champ, Attorney-in-Fact 2009-02-13 -----END PRIVACY-ENHANCED MESSAGE-----